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We have previously reported that supplementation with folic acid (1.2mgday
 1 for 12 week) elicited a significant improvement in
the folate status of 61 healthy volunteers. We have examined effects of this supplement on markers of genomic stability. Little is
known about the effect of folate supplementation on DNA stability in a cohort, which is not folate deficient. Preintervention, there
was a significant inverse association between uracil misincorporation in lymphocyte DNA and red cell folate (Po0.05). In contrast,
there were no associations between folate status and DNA strand breakage, global DNA methylation or DNA base excision repair
(measured as the capacity of the lymphocyte extract to repair 8-oxoGua ex vivo). Folate supplementation elicited a significant
reduction in uracil misincorporation (Po0.05), while DNA strand breakage and global DNA methylation remained unchanged.
Increasing folate status significantly decreased the base excision repair capacity in those volunteers with the lowest preintervention
folate status (Po0.05). Uracil misincorporation was more sensitive to changes in folate status than other measures of DNA stability
and therefore could be considered a specific and functional marker of folate status, which may also be relevant to cancer risk in
healthy people.
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Epidemiological studies have consistently revealed an association
between the consumption of fruit and vegetables and reduced
incidence of cancers at various sites. Although the active dietary
components have not been identified, folate has received a
significant amount of attention. A relative deficiency of folate
has been associated with precancerous lesions or cancer of the
breast, large bowel, cervix, oesophagus, lung and pancreas
(Jaskiewicz et al, 1988; Jaskiewicz, 1989; Van Eenwyk et al, 1990;
Lashner, 1993; Duthie, 1999; Giovannucci, 2002; Zhang et al, 2003).
There are currently thought to be two main routes whereby
folate deficiency might increase malignant transformation, both
reflecting the importance of folate in 1-C metabolism. The first
deals with the role of folate in normal DNA synthesis and DNA
repair. Folate is essential for the de novo synthesis of purines (A
and G) and pyrimidines (T and C), which are required during the
replication and repair of DNA. Folate in the form 5,10
methylenetetrahydrofolate is essential for the conversion of
deoxyuridylate to thymidylate, but when folate is limiting, uracil
is misincorporated into DNA which may ultimately lead to DNA
double-strand breakage, chromosomal damage and malignant
transformation (Reidy, 1988; Blount and Ames, 1994). Increased
uracil misincorporation into DNA has been reported in various in
vitro systems under a folate restricted environment (Libbus et al,
1990; Wickramasinghe and Fida, 1993; Branda et al, 1994; James
et al, 1994; Duthie and Hawdon, 1998; Melnyk et al, 1999). The
negative effect of folate deficiency on genomic stability is also
supported by studies in animals fed folate-depleted diets (James
and Yin, 1998; Duthie et al, 2000a). Evidence for the effects of
folate status on uracil misincorporation in humans is scarce but
there is some evidence that uracil misincorporation into lympho-
cyte and bone marrow cell DNA is increased in folate deficiency
(Wickramasinghe and Fida, 1994; Blount et al, 1997). In addition
to altered thymidine synthesis, purine biosynthesis is negatively
affected by low folate (10-formyltetrahydrofolate), thereby limiting
the availability of nucleotides for DNA synthesis and repair, which
will also have consequences for genomic stability. Repair of
oxidative DNA damage is compromised in folate deficient cultured
human and rat colonocytes ex vivo (Duthie et al, 2000b, c). It
remains to be established whether increasing folate availability can
improve DNA repair activity.
The second route whereby folate status may influence cancer
risk is via its function in DNA methylation and gene expression.
Folate, in the form 5-methyltetrahydrofolate (5-MeTHF), acts as
methyl donor in the remethylation of homocysteine to methionine,
which in turn is converted to S-adenosylmethionine (SAM).
S-adenosylmethionine is the direct methyl donor in the methyla-
tion of DNA. Folate deficiency, by limiting cellular SAM levels,
may induce global DNA hypomethylation and increase the risk of
malignant transformation. While it is generally accepted that
extreme methyl depletion alters DNA methylation and increases
cancer risk in rodents, the effect of folate deficiency alone on
cytosine methylation is not so clear. Hepatic DNA is hypomethy-
lated in rats fed a folate depleted diet for 4 weeks (Balaghi and
Wagner, 1993), while folate deficiency results in the preferential
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shypomethylation of exons 6 and 7 of p53 in rat colon (Kim et al,
1995). Conversely, other studies have described no effect of
moderate folate deficiency on DNA hypomethylation (global or
site-specific) in rat liver or colon (Kim et al, 1995; Duthie et al,
2000c; Sohn et al, 2003). The data suggesting a role for folate in
modulating DNA methylation in humans is equally inconsistent.
Global DNA hypomethylation has been reported to be increased in
lymphocytes isolated from elderly women with folate deficiency
(Jacob et al, 1998; Rampersaud et al, 2000). In contrast, global
DNA methylation was found not to be influenced by folate status
in a study of younger subjects (Fenech et al, 1998). Little is known
about the effect of folate supplementation on global DNA
methylation in healthy nonfolate deficient human volunteers.
The enzyme methylenetetrahydrofolate reductase (MTHFR; EC
1.5.1.20), responsible for the conversion of 5,10-methyleneTHF to
5-MeTHF, is polymorphic, with 5–15% of populations homo-
zygous for the variant C677T, which decreases the efficiency of the
enzyme (Frosst et al, 1995). The associated decrease in 5-MeTHF
might be expected to lead to global DNA hypomethylation and an
increased risk of cancer. However, this mutation might also be
expected to lead to an increase in 5,10-methyleneTHF (Bagley and
Selhub, 1998), which should drive increased thymidine production
for DNA synthesis and repair. Homozygosity for C677T is
associated with a reduced risk of colorectal cancer in subjects
with good folate status (Ma et al, 1997), suggesting that the impact
that folate status has on genomic stability and repair may be
significant in the process of malignant transformation and
indicating that uracil misincorporation may indeed be an
important early cancer biomarker in humans. The importance of
this genotype to cancer risk at other sites is less clear.
There is no evidence in the literature for effects of increasing
folate status on DNA stability (uracil misincorporation, global
strand breakage, DNA base excision repair activity or global DNA
methylation) in healthy nonfolate deficient volunteers, even
though this group is most commonly used to report epidemiolo-
gical links between diet and cancer. In the present study, we
evaluated the effects of improving folate status on markers of DNA
stability in lymphocytes.
MATERIALS AND METHODS
Volunteer selection and sample size
Volunteers were recruited to the study as previously reported
(Basten et al, 2004). Briefly, a randomised double-blind placebo-
controlled, folic acid intervention trial was carried out in healthy
men and women (20–60 years). Volunteers who were pregnant or
planning a pregnancy, receiving medical care, taking methotrexate,
antiepileptic drugs or vitamin supplements, who were smokers or
who had a red cell folate (RCF) concentration less than
200nmoll
 1 (folate deficient; UK Department of Health) were
excluded. DNA methylation acceptance in isolated lymphocytes
from human volunteers decreased by 38% when folate intake
increased from 100 to 516mg day
 1 (Jacob et al, 1998). To detect a
similar improvement in DNA methylation in response to folate
supplementation with a power of 95% and a probability of 5%
would require 28 subjects per group. We aimed to recruit 30 per
group to allow for drop-outs from the study. The study was
reviewed and approved by the North Sheffield Ethics Office of the
Sheffield Teaching Hospitals NHS Trust, UK. Written informed
consent was obtained from all subjects.
Intervention dose
Volunteers were randomised to receive either 1.2mg folic acid
(pteroylglutamic acid) or glucose placebo, daily for 12 weeks. The
folate dose represents a significantly higher dose than the current
UK and US recommended nutrient intake of 200mg for adults, but
is considerably lower than the pharmacological doses used in
many clinical trials (Areekul et al, 1980; Butterworth et al, 1992;
McGregor et al, 2000; Kim et al, 2001; Cafolla et al, 2002).
Intervention capsules were manufactured by the Clinical Directo-
rate of Pharmacy Services, Sheffield Teaching Hospitals NHS
Trust, UK.
Specimen collection
As described previously (Basten et al, 2004) subjects were initially
screened for RCF status by donating a 500ml sample of whole
blood, obtained from the finger tip using a pro-lancet device
(Roche, UK) into an EDTA coated tube (Startsedt, UK). In all, 65
subjects with RCF between 250 and 650nmoll
 1 were recruited to
the intervention trial. This range represents a less than average
folate status for the adult UK population, while excluding folate
deficient volunteers. Volunteers donated a 20ml sample of 16h
fasted blood into EDTA-containing evacuated tubes at week 0, and
following 12 weeks of supplementation. Lymphocytes were
prepared from fresh whole blood collected at week 0 and week
12 with and specifically stored in duplicate for the later
measurement of DNA stability markers.
Lymphocyte preparation to measure uracil
misincorporation, DNA strand breakage, DNA base
excision repair and global DNA methylation
Human lymphocytes were isolated as described previously (Basten
et al, 2004). In brief, whole blood was centrifuged at 1500g at 41C
for 15min. The ‘buffy coat’ layer was removed, re-suspended in
RPMI media (Gibco, UK), and layered onto an equal volume of
lymphoprep gradient solution (Robbins Scientific, UK). Following
centrifugation at 700g, 251C for 30min, the cells were washed three
times using RPMI (251C, 15min, 700g), and counted using either a
haemocytometer or automated cell counter (Coulter, Fullerton,
CA, USA). For the measurement of uracil misincorporation, DNA
strand breakage and DNA methylation 500ml of lymphocytes were
cryopreserved in 90% FCS/10% DMSO at a final cell density of
3 10
6ml
 1 and stored at –801C. For the measurement of base
excision repair capacity the final cell pellet was resuspended in
extraction buffer at a cell density of 10
7/100ml, snap frozen in
liquid nitrogen and stored at  801C.
Lymphocyte uracil misincorporation and DNA strand
breakage status
DNA instability (strand breaks and misincorporated uracil) was
measured in lymphocytes isolated by single cell gel electrophoresis
as described previously (Duthie and McMillan, 1997; Narayanan
et al, 2001). A total of 100 comet images from each gel (with
duplicate gels per subject) were classified according to the
intensity of fluorescence in the comet tail representing damaged
cells. Images were scored randomly across each gel and the
experimenter was blind to the intervention. DNA strand breakage
was estimated based only on the score obtained from buffer-
treated gels. Misincorporated uracil was measured by subtracting
the visual score obtained from buffer-treated gels (endogenous
strand breakage) from the score obtained after incubation with
uracil DNA glycosylase (strand breakage due to the excision of
uracil). This method of classification has been validated exten-
sively by computerised image analysis (Komet 3.0, Kinetic Imaging
Ltd, Liverpool, UK) (Duthie and Hawdon, 1998). Quality control
was maintained through the use of a standard lymphocyte lysate,
which was independently validated and quantified through
internal quality control procedures. All measurements were made
blind to code and quality control standard. The coefficient of
variation for the assay was below 13%.
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Base excision repair capacity in supplemented or unsupplemented
volunteers was assessed as the ability of cell-free extract (prepared
from isolated lymphocytes as above) to excise 8-oxo-7,8-dihydro-
guanine (8-oxoGua) from substrate DNA isolated from CHO cells
treated with either PBS or RO19-8022 and light (Collins et al,
2001). Rate of excision of 8-oxoGua was detected as an increase in
DNA strand breaks using conventional SCGE as described
previously (Collins, 2004). DNA incision was calculated as the
net increase in DNA strand breakage in RO-treated cells incubated
with lymphocyte lysate from 0 to 20min after subtracting
equivalent scores from PBS-treated cells incubated with extract.
In this way, any nonspecific incision activity due to incubation at
371C with extract alone was accounted for. The coefficient of
variation across the study was below 22%.
Lymphocyte DNA methylation status
DNA was isolated from lymphocytes using a Qiagen DNA Blood
Mini kit. Total genomic DNA methylation was determined by
measuring incorporation of methyl groups from
3H-labeled S-
adenosyl-L-methionine at specific cytosine residues using the
bacterial enzyme Sss1 methylase. DNA methylation status is
inversely related to the degree of radioactive incorporation, that is
the lower the methylation of the DNA the higher the disintegra-
tions per minute (DPM) (Balaghi and Wagner, 1993). Standard
lymphocyte DNA was coanalysed with each group of samples. The
coefficient of variation for the assay was 6.9%.
Measurement of whole blood SAM by HPLC-UV
For the measurement of SAM concentration, 100ml of whole blood
were deproteinised in 900ml of 6% perchloric acid (w/v) and stored
at  801C. S-adenosylmethionine was measured using a modified
HPLC assay based on published methods (Bottigleri, 1990; Loehrer
et al, 1996). SAH is present in blood in much lower concentrations
than SAM and the method employed was not adequate to quantify
SAH with the desired degree of precision. A Gilson G715 HPLC
with autoinjector (G234 was used, with samples held at a
temperature of 41C, one pump (G305) and a UV detector (G116),
on a Nucleosil 100 C8 column (250 4.6mm) (Supelco, UK) with a
mobile phase of 0.1 M sodium acetate and 2% acetonitrile (pH 4.5).
The flow rate was 1mlmin
 1, with detection at 254nm (0.01
AUFS) and using an injection volume of 50ml. Inter-batch
coefficient of variation was 8.2%
MTHFR Genotype
A whole blood aliquot was stored at  801C for the later
determination of MTHFR genotype. MTHFR genotype was
determined using a modification of published methods (Frosst
et al, 1995; Clark et al, 1998). The DNA was isolated from whole
blood according the QIAamp DNA Mini Kit protocol (Qiagen, UK)
and the DNA quantified using a Picogreen dye (Molecular Probes,
Netherlands). MTHFR genotype was determined by polymerase
chain reaction (PCR) using primers: sense 50-TGAAGGA
GAAGGTGTCTGCGGGA-30, antisense: 50-AGGACGGTGCGGTGA
GAGTG-30. Predetermined MTHFR genotype control DNA was a
kind gift from Dr P Guthrie, North Trent Molecular Genetics
Laboratory, Sheffield Children’s Hospital, UK.
Data analysis
Statistical analyses were performed with SPSS software, version
12.0 (SPSS Inc., Chicago). Correlations between variables were
evaluated with the use of Spearman’s rank-order coefficient of
correlation. Kruskal–Wallis nonparametric independent samples
test was used to evaluate the effect of intervention, using
percentage change from baseline as test variable against inter-
vention (folate or placebo) as grouping variable. All tests were
two-tailed and were considered significant when Po0.05.
RESULTS
Preintervention biochemical measurements
A total of 61 volunteers completed the intervention. The
supplement group consisted of 15 men and 15 women, mean ages
42 year. (79 year) and the placebo group consisted of 15 men and
16 women, 40 year. (78 year). We have previously reported a
significant effect of folic acid supplementation on measures of
folate status and function (Basten et al, 2004). This report
examines associated effects on measures of DNA stability and
repair.
Plasma concentration of SAM, and measures of DNA stability
and repair are shown in Table 1. Values are shown for samples
collected pre- and post intervention. Although we specifically
recruited self-reported nonsmokers plasma cotinine concentra-
tions suggested that 10 subjects had been exposed to sufficient
tobacco smoke to elevate plasma cotinine. However, plasma
cotinine was not significantly associated with any measure of
folate status or DNA stability and appears not to be a confounder
Table 1 Pre- and Postintervention biochemical variables
Intervention
Variable Group Pre Post
Whole blood SAM (mmol/l) Folate 0.03 (0.03–1.04) 0.85 *(0.03–2.3)
Placebo 0.07 (0.03–1.26) 0.07 (0.03–0.88)
Uracil misincorporation (arbitrary units) Folate 51 (41–60) 40 ** (30–46)
Placebo 47 (40.0–57.3) 42.5 (33.5–56.5)
Strand breaks (arbitrary units) Folate 80 (68–96) 92 (71–103)
Placebo 88 (71–99) 85 (68.3–107)
DNA incisions (BER-arbitrary units) Folate 63 (34–85) 52 (31–81)
Placebo 63 (40–93) 76 (53–93)
DNA methylation (incorporated/0.5mg DNA) Folate 17508 (10631–19892) 15099 (12514–20121)
Placebo 16099 (13512–18717) 17942 (14849–20732)
Median (interquartile range), *Po0.01, **Po0.05 response to intervention significantly different from placebo group.
Folic acid supplementation and markers of DNA damage
GP Basten et al
1944
British Journal of Cancer (2006) 94(12), 1942–1947 & 2006 Cancer Research UK
G
e
n
e
t
i
c
s
a
n
d
G
e
n
o
m
i
c
sin this study. There was no significant effect of MTHFR C677T
genotype on any of the preintervention measures of DNA stability.
This should be expected, however, as the recruitment was not
based on genotype, and because of this the numbers with the TT
variant were small (supplement n¼3, placebo n¼4). There was a
significant negative association between preintervention uracil
misincorporation and RCF (Po0.01 r¼ 0.5). There was, how-
ever, no significant association between any marker of preinter-
vention folate status and baseline DNA methylation, DNA strand
breakage, or the base excision repair capacity.
Effects of folic acid supplementation
As previously reported, folate supplementation elicited a signifi-
cant increase in plasma 5-MeTHF, red cell folate and lymphocyte
total folate compared with the control group (Po0.01) (Basten
et al, 2004). We now show that folate supplementation significantly
increased whole blood SAM (Po0.01). The increased concentra-
tion of SAM was closely associated with the increase in red cell
folate and plasma 5-MeTHF concentrations (Po0.01). Similarly,
supplementation elicited a significant (Po0.01) reduction in
plasma homocysteine compared with the control group (Basten
et al, 2004).
A significant decrease in uracil misincorporation (Po0.05) was
observed in the folate-supplemented group compared with control.
There was a small decrease in uracil misincorporation observed in
the placebo group, but this was not significant. Moreover, there
was a strong correlation between the magnitude of the increase in
lymphocyte total folate and reduction in lymphocyte DNA uracil
misincorporation (Figure 1; Po0.01 r¼ 0.49). There was also a
significant negative association between changes in uracil mis-
incorporation and changes in plasma 5-methyl THF (Po0.01,
r¼ 0.48) and RCF (Po0.01, r¼ 0.46). Uracil misincorporation
was examined according to preintervention quartiles of RCF
status. The effect of folate supplementation was even more
pronounced in the lowest quartile of preintervention RCF;
although the numbers are small (n¼7) the observation is still of
interest.
Conversely, DNA strand breakage and global DNA methylation
were unaffected by supplementation and no associations were
observed between these markers of DNA stability and folate status
either when analysed as groups or when stratified by RCF status.
Folate supplementation had no effect on the capacity of the
lymphocyte lysate to repair 8-oxoGua ex vivo when using the data
from the whole study. The capacity of the lymphocyte lysate to
repair 8-oxoGua ex vivo was then examined according to
preintervention quartiles of RCF status. In the lowest quartile,
folate supplementation elicited a significant decrease in the
number of base incisions compared with control (Po0.05)
(Figure 2).
DISCUSSION
Low intake of folic acid has been implicated in the development of
certain epithelial cell cancers (Jaskiewicz et al, 1988; Jaskiewicz,
1989; Van Eenwyk et al, 1990; Lashner, 1993; Giovannucci, 2002;
Zhang et al, 2003). Folate deficiency has been hypothesised to
increase cancer risk either by perturbing DNA synthesis and repair
(Reidy, 1988; Blount and Ames, 1994) or by inducing DNA
hypomethylation and negatively affecting gene expression (Balaghi
and Wagner, 1993). However, putative biomarkers of folate status
related to cancer risk have not been adequately explored in healthy
volunteers. In order for a marker of folate status to be useful as a
biomarker of cancer risk, it must be sensitive to changes in folate
intake in healthy people. We conducted a randomised, double
blind, placebo-controlled intervention trial in healthy volunteers to
investigate whether putative biomarkers of DNA stability were
sensitive to a 12-week supplementation with 1.2mg folic acid. We
have previously reported significant improvement in measures of
folate status in plasma, red blood cells and lymphocytes, and a
reduction in plasma homocysteine (Basten et al, 2004). The present
report reveals that folate supplementation increases whole blood
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uracil misincorporation.
0
50
100
150
200
250
Week 0
Week 12
NS 
**
D
N
A
 
i
n
c
i
s
i
o
n
s
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
)
 
Folate Placebo
Intervention
Figure 2 Effect of folate supplementation on DNA incision (lowest RCF
quartile).
Folic acid supplementation and markers of DNA damage
GP Basten et al
1945
British Journal of Cancer (2006) 94(12), 1942–1947 & 2006 Cancer Research UK
G
e
n
e
t
i
c
s
a
n
d
G
e
n
o
m
i
c
sSAM and elicits a significant effect on some measures of DNA
stability and repair.
Uracil misincorporation into lymphocyte DNA was negatively
associated with measures of folate status at baseline (RCF) and
postintervention (RCF, lymphocyte folate, plasma folate). Of
particular interest, however, is that in this study, folate supple-
mentation significantly decreased misincorporated uracil in
lymphocyte DNA but did not alter global DNA strand breakage
or DNA methylation, confirming the importance of folate in the
synthesis of thymidine. This reduction in uracil following folate
supplementation was most pronounced in those with the poorest
folate status at baseline and while the number of subjects is small,
the observation indicates that an important functional deficit is
readily corrected by folic acid supplementation. These results are
consistent with effects reported in two patient groups. There have
been two other reports of effects of folate status on uracil
incorporation in DNA. Blount et al (1997) observed an effect of
high-dose folic acid in splenectomised patients. Wickramasinghe
and Fida (1994) reported increased uracil incorporation in DNA in
patients with megaloblastic anaemia compared to three healthy
control subjects. However, we believe this is the first study to show
that folic acid supplementation in healthy human volunteers who
are not folate deficient, can decrease uracil misincorporation.
Uracil in DNA is also reported to decrease in human
lymphocytes and colonocytes cultured with increasing concentra-
tions of folic acid (Wickramasinghe and Fida, 1994; Duthie et al,
2000b). Conversely rats fed a folate-deficient diet for 10 weeks
exhibited elevated uracil misincorporation into lymphocyte DNA
(Duthie et al, 2000a). Additional restriction of dietary methionine
and choline, both dependent upon folate for their metabolism,
increased DNA strand breakage in blood cells but had no effect on
uracil misincorporation, confirming the specificity and depen-
dency of this biomarker on folate status.
To our knowledge, this is the first human study to determine the
effects of folate supplementation on DNA base excision repair
capacity. DNA repair is crucial in maintaining genomic stability
and compromised DNA repair is associated with increased risk of
malignancy (Reidy, 1988; Blount and Ames, 1994). Given the
profound influence that folate status has on DNA metabolism, and
preliminary indications that folate deficiency can negatively
influence repair of oxidative DNA damage in vitro (James and
Yin, 1998; Duthie et al, 2000a), it might be expected that DNA base
excision repair capacity could be improved by increasing folate
intake. Despite significant increases in blood and lymphocyte
folate levels, supplementation in the intervention group as a whole
did not alter initiation of DNA base excision repair. This suggests
that DNA repair activity might not be altered by increasing folate
intakes in people with adequate folate status as determined by
conventional measures. However, in the lowest preintervention
RCF quartile, folate supplementation significantly decreased DNA
repair incision activity compared to placebo. A definitive
explanation for this surprising observation is lacking at this time,
although it may simply reflect a downregulation in repair activity
due to increased provision of nucleosides following folate
supplementation in this relatively depleted subgroup. This remains
to be established.
Global DNA hypomethylation is considered to be an important
epigenetic event in the development of several human neoplasms
(Esteller and Herman, 2002). Folate deficiency has been hypo-
thesised to increase cancer risk by reducing the availability of SAM
for methylation of specific cytosine residues in DNA thereby
permitting inappropriate proto-oncogene expression and subse-
quent malignant transformation. Folate deficiency in rats has been
shown to decrease SAM in several tissues, but with little effect on
DNA methylation (Sohn et al, 2003). Conversely, folate supple-
mentation has been reported to decrease global DNA hypomethy-
lation in seven of 20 patients with resected colonic adenomas
(Cravo et al, 1998). In our healthy population, folate supplementa-
tion increased whole blood SAM but did not alter lymphocyte
global DNA methylation. It would have been preferable to have
determined the SAM:SAH ratio, as this has been reported to be
more strongly related to DNA methylation than SAM alone (Sibani
et al, 2002), but this was not possible using the method available to
us at the time. Two previous studies suggested that folate depletion
of healthy women leads to lymphocyte global DNA hypomethyla-
tion (Jacob et al, 1998; Rampersaud et al, 2000). We have examined
responses to increasing folate intakes in healthy men and women
with intakes above current daily recommendations and found no
effect. This may reflect insufficient sensitivity of the method
employed but equally may reflect the fact that global DNA
methylation in a healthy population may be more sensitive to
folate depletion than to supplementation.
Although volunteers were not recruited on the basis of genotype,
and the study was not powered to identify differences in outcomes
according to genotype (only seven subjects homozygous for
MTHFR C677T) we did explore this possibility. MTHFR genotype
had no influence on any measure of DNA stability or DNA
methylation status in this study, although the authors emphasise
the fact that numbers carrying the TT variant were relatively
small.
In summary, supplementation with 1.2mg folic acid in a healthy
population resulted in a significant increase in several indices of
blood folate status with a concomitant decrease in misincorpora-
tion of uracil into cellular DNA, particularly in the lowest quartile
of RCF at baseline. DNA strand breakage, global DNA methylation
status and DNA repair capacity in response to oxidative DNA
damage remained unchanged in the supplemented group as a
whole, although in those subjects with the lowest RCF initially,
supplementation decreased DNA incision repair. The mechanism
behind this observation remains to be established.
Uracil misincorporation is evidently more sensitive to improved
folate status in healthy individuals than other putative biomarkers
of DNA damage or repair and may, therefore, be considered a valid
and functional biomarker for the influence of folate on genomic
stability in healthy people.
ACKNOWLEDGEMENTS
We are grateful to the volunteers who took part in the study. The
study was funded by the World Cancer Research Fund UK and the
Scottish Executive Environmental Rural Affairs Department.
REFERENCES
Areekul S, Subcharoen A, Cheeramakara C, Srisukawat K, Limsuwan S
(1980) Studies on the effect of folic acid supplement on folate and
vitamin B12 status in children. Southeast Asian J Trop Med Public Health
11(1): 81–86
Bagley PJ, Selhub JA (1998) Common mutation in the methylenetetrahydrofolate
reductase gene is associated with an accumulation of formylated tetrahy-
drofolates in red blood cells. Proc Natl Acad Sci USA 95(22): 13217–13220
Balaghi M, Wagner C (1993) DNA methylation in folate deficiency: use of
CpG methylase. Biochem Biophys Res Commun 193(3): 1184–1190
Basten GP, Hill MH, Duthie SJ, Powers HJ (2004) Effect of folic acid
supplementation on the folate status of buccal mucosa and lymphocytes.
Cancer Epidemiol Biomarkers Prev 13(7): 1244–1249
Blount BC, Ames BN (1994) Analysis of uracil in DNA by gas
chromatography-mass spectrometry. Anal Biochem 219(2): 195–200
Folic acid supplementation and markers of DNA damage
GP Basten et al
1946
British Journal of Cancer (2006) 94(12), 1942–1947 & 2006 Cancer Research UK
G
e
n
e
t
i
c
s
a
n
d
G
e
n
o
m
i
c
sBlount BC, Mack MM, Wehr WM (1997) Folate deficiency causes uracil
misincorporation into human DNA and chromosomal breakage:
Implications for cancer and neuronal damage. Proc Natl Acad Sci 94:
3290–3295
Bottigleri T (1990) High performance liquid chromatography analysis of
s-adenosylmethionine and s-adenosylhomocystine in animal tissues: the
effect of exposure to nitrous oxide. Biomed Chromatogr 4: 239–241
Branda RF, Lafayette AR, ONeill JP, Nicklas JA (1994) Effect of folate
deficiency on mutations at the HPRT locus in Chinese hamster ovary
cells exposed to monofunctional alkylating agents. Cancer Res 57(13):
2586–2588
Butterworth Jr CE, Hatch KD, Soong SJ, Cole P, Tamura T, Sauberlich HE,
Borst M, Macaluso M, Baker V (1992) Oral folic acid supplementation for
cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol
166(3): 803–809
Cafolla A, Dragoni F, Girelli G (2002) Effect of folic acid and vitamin C
supplementation on folate status and homocysteine level: a randomised
controlled trial in Italian smoker-blood donors. Atherosclerosis 163(1):
105–111
Clark ZE, Bowen DJ, Whatley SD, Bellamy MF, Collins PW, McDowell IF
(1998) Genotyping method for methylene tetrahydrofolate reductase
(C677T thermolabile variant) using heteroduplex technology. Clin Chem
44: 2360–2362
Collins AR (2004) The comet assay for DNA damage and repair: principles,
applications, and limitations. Mol Biotechnol 26(3): 249–261
Collins AR, Dusinska M, Horvathova E, Munro E, Savio M, Stetina R (2001)
Inter-individual differences in repair of DNA base oxidation, measured
in vitro with the comet assay. Mutagenesis 16: 297–301
Cravo ML, Pinto AG, Chaves P, Cruz JA, Lage P, Nobre Leitao C, Costa Mira
F (1998) Effect of folate supplementation on DNA methylation of rectal
mucosa in patients with colonic adenomas: correlation with nutrient
intake. Clin Nutr 17(2): 45–49
Duthie SJ (1999) Folic acid deficiency and cancer: mechanisms of DNA
instability. Br Med Bull 55(3): 578–592
Duthie SJ, Grant G, Narayanan S (2000a) Increased uracil misincorporation
in lymphocytes from folate-deficient rats. Br J Cancer 83: 1532–1537
Duthie SJ, Hawdon A (1998) DNA instability (strand breakage, uracil
misincorporation, and defective repair) is increased by folic acid
depletion in human lymphocytes in vitro. FASEB 12(4): 1491–1497
Duthie SJ, McMillan P (1997) Uracil misincorporation in human DNA
detected using single cell gel electrophoresis. Carcinogenesis 18(9):
1709–1714
Duthie SJ, Narayanan S, Blum S, Pirie L, Brand GM (2000b) Folate
deficiency in vitro induces uracil misincorporation and DNA hypo-
methylation and Inhibits DNA excision repair in immortalised human
colon epithelial cells. Nutr Cancer 37(2): 245–251
Duthie SJ, Narayanan S, Brand M, Grant G (2000c) DNA stability and
genomic methylation status in colonocytes isolated from methyl donor-
deficient rats. Eur J Nutr 39: 106–111
Esteller M, Herman JG (2002) Cancer as an epigenetic disease: DNA
methylation and chromatin alterations in human tumours. J Pathol
196(1): 1–7
Fenech M, Aitken C, Rinaldi J (1998) Folate. vitamin B12, homocysteine
status and DNA damage in young Australian adults. Carcinogenesis 7:
1163–1171
Frosst P, Blom HJ, Milos R (1995) A candidate genetic risk factor for
vascular disease: a common mutation in methylene tetrahydrofolate
reductase. Nat Genet 10: 111–113
Giovannucci E (2002) Epidemiologic studies of folate and colorectal
neoplasia: a review. J Nutr 132(8 Suppl): 2350S–2355S
Jacob RA, Gretz DM, Taylor PC (1998) Moderate folate depletion increases
plasma homocysteine and decreases lymphocyte DNA methylation in
postmenopausal women. J Nutr 128(7): 1204–1212
James SJ, Basnakian AG, Miller BJ (1994) In vitro folate deficiency induces
deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese
hamster ovary cells. Cancer Res 54: 5075–5080
James SJ, Yin L (1998) Diet induced DNA damage and altered nucleotide
metabolism in lymphocytes from methyl-donor-deficient rats. Carcino-
genesis 10: 1209–1214
Jaskiewicz K (1989) Oesophageal carcinoma: cytopathology and nutritional
aspects in aetiology. Anticancer Res 9: 1847–1852
Jaskiewicz K, Marasas WFO, Lazarus C, Beyers AD, van Helden PD (1988)
Association of oesophageal cytological abnormalities with vitamin and
lipotrope deficiencies in populations at risk for oesophageal cancer.
Anticancer Res 8: 711–716
Kim YI, Baik HW, Fawaz K (2001) Effects of folate supplementation on two
provisional molecular markers of colon cancer: a retrospective,
randomised trial. Am J Gastroenterol 96: 184–195
Kim YI, Christman JK, Fleet JC (1995) Moderate folate deficiency does not
cause global hypomethylation of hepatic and colonic DNA or c-myc-
specfic hypomethylation of colonic DNA in rats. Am J Clin Nutr 61:
1083–1090
Lashner BA (1993) Red cell folate is associated with the development of
dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 119:
549–554
Libbus BL, Borman LS, Ventrone CH, Branda RF (1990) Nutritional folate-
deficiency in Chinese hamster ovary cells. Chromosomal abnormalities
associated with perturbations in nucleic acid precursors. Cancer Genet
Cytogenet 46(2): 231–242
Loehrer FM, Angst CP, Haefeli WE, Jordan PP, Ritz R, Fowler B (1996) Low
whole-blood S-adenosylmethionine and correlation between 5-methylte-
trahydrofolate and homocysteine in coronary artery disease. Arterioscler
Thromb Vasc Biol 16(6): 727–733
Ma J, Stampfer MJ, Giovannucci E (1997) Methylenetetrahydrofolate
reductase polymorphism, dietary interactions, and risk of colorectal
cancer. Cancer Res 15 57(6): 1098–1102
McGregor D, Shand B, Lynn K (2000) A controlled trial of the effect of
folate supplements on homocysteine, lipids and hemorheology in end-
stage renal disease. Nephron 85(3): 215–220
Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP, James SJ
(1999) Uracil misincorporation, DNA strand breaks, and gene amplifica-
tion are associated with tumorigenic cell transformation in folate
deficient/repleted Chinese hamster ovary cells. Cancer Lett 146(1):
35–44
Narayanan S, O’Donovan MR, Duthie SJ (2001) Lysis of whole blood in
vitro causes DNA strand breaks in human lymphocytes. Mutagenesis
6(6): 455–459
Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB (2000)
Genomic DNA methylation decreases in response to moderate folate
depletion in elderly women. Am J Clin Nutr 72(4): 998–1003
Reidy JA (1988) Role of deoxyuridine incorporation and DNA repair in the
expression of human chromosomal fragile sites. Mutat Res 200(1–2):
215–220
Sibani S, Melnyk S, Pogribny IP, Wang W, Hiou-Tim F, Deng L, Trasler J,
James SJ, Rozen R (2002) Studies of methionine cycle intermediates
(SAM, SAH), DNA methylation and the impact of folate deficiency on
tumour numbers in Min mice. Carcinogenesis 23(1): 61–65
Sohn KJ, Stempak JM, Reid S, Shirwadkar S, Mason JB, Kim YI (2003) The
effect of dietary folate on genomic and p53-specific DNA methylation in
rat colon. Carcinogenesis 24(1): 81–90
Van Eenwyk J, Davis FG, Colman N (1990) Folate, vitamin C and
cervical intraepithelial neoplasia. Cancer Epidemiol Biomark Prev 1:
651–652
Wickramasinghe SN, Fida S (1993) Misincorporation of uracil into
the DNA of folate and B12-deficient HL 60 cells. Eur J Haematol 50:
127–132
Wickramasinghe SN, Fida S (1994) Bone marrow cells from vitamin B12
and folate-deficient patients misincorporate uracil into DNA. Blood 83:
1656–1661
Zhang SM, Willett WC, Selhub J (2003) Plasma folate, vitamin B6, vitamin
B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95(5):
373–380
Folic acid supplementation and markers of DNA damage
GP Basten et al
1947
British Journal of Cancer (2006) 94(12), 1942–1947 & 2006 Cancer Research UK
G
e
n
e
t
i
c
s
a
n
d
G
e
n
o
m
i
c
s